fig1
From: HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer
Figure 1. Structures of clinically and preclinically tested HDAC inhibitors. HDAC: Histone deacetylase; CRPC: castration-resistant prostate cancer.
